Table 7.
Examples of FDA-approved polysaccharide conjugate vaccines.
| Pathogen | Vaccine Tradename | Route of Administration | Adjuvant | Manufacturer |
|---|---|---|---|---|
| Haemophilus B Vaccine (Meningococcal Protein Conjugate) | Liquid PedvaxHIB® | Intramuscular | - | Merck & Co., Inc. Kenilworth, NJ, USA |
| Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) | HIBERIX® | Intramuscular | - | GlaxoSmithKline Biologicals. Brentford, UK |
| Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) | Prevnar 13® | Intramuscular | Aluminum Phosphate | Pfizer Inc, Inc. New York, NY, USA |
| Pneumococcal 15-valent Conjugate Vaccine | VAXNEUVANCE® | Intramuscular | Aluminum Phosphate | Merck & Co., Inc. Kenilworth, NJ, USA |
| Haemophilus b Conjugate Vaccine (Tetanus Toxoid Conjugate) | ActHIB® | Intramuscular | - | Sanofi Pasteur, SA. Lyon, France |
| Meningococcal (Groups A, C, Y, W) Conjugate Vaccine | MenQuadfi® | Intramuscular | - | Sanofi Pasteur, Inc. Lyon, France |